electroCore (ECOR)
(Delayed Data from NSDQ)
$5.91 USD
-0.29 (-4.68%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $5.91 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
electroCore, Inc. [ECOR]
Reports for Purchase
Showing records 21 - 37 ( 37 total )
Company: electroCore, Inc.
Industry: Medical - Drugs
GammaCore Commercialization Through UK Online Shop; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Base Business Growth Continues; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
VA/DOD Helps Deliver a Strong 3Q21; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Company: electroCore, Inc.
Industry: Medical - Drugs
2021 Growth Momentum Continues; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Revenue Diversification to Aid Growth in 2021 And Beyond; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Growth Momentum Continues Into 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Multi-Pronged Growth in 2021 and Beyond; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Well Executed 2020 Bolsters our Confidence in Long-Term Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Repositioning Revenue Channels for Long-Term Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Preliminary 3Q20 Revenues Signal Strong 2H20 and Stronger 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
UK Sales Could Grow Further With ITP Extension; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Expect Operating Efficiency Improvement to Continue; Higher $3 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
EUA Received; Telehealth Mitigates Pandemic Impact; Higher $2.50 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Sales Trajectory Remain Intact Despite the Pandemic; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
FSS and UK Channels Continue to Grow; Lower $1.50 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: electroCore, Inc.
Industry: Medical - Drugs
Zap Away Headaches With gammaCore; Initiate With Buy and a $2 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S